|
|
A comparison of B2B marketing tools of selected pharmaceutical distributors
Vanková, Ivana ; Průša, Přemysl (advisor) ; Postler, Milan (referee)
The diploma thesis deals with a comparison of B2B marketing tools of the biggest pharmaceutical distributors on the Czech market. Alliance Healthcare is one of the leading distributors in this area and would like to increase its turnover and gain new clients. The aim of the thesis is to define marketing tools of all pharmaceutical distributors, make a questionnaire based on this topic that will be sent to customers of the biggest companies and find out how the particular tools are evaluated by the pharmacies and what the position of Alliance Healthcare in comparison to its competitors is. After the evaluation of the questionnaire recommendations that could help Alliance Healthcare to reach its goal follow.
|
|
|
Strategy for New Products for the Pharmaceutical Market
Gálová, Dagmar ; Zinecker, Marek (referee) ; Luňáček, Jiří (advisor)
The bachelor thesis on "Strategies of putting a new product on the pharmaceutical market" presents a realistic scenario that will later be used by a particular company for launching a new product. The thesis is specific in that it deals with the pharmaceutical market, which is one of the heavily regulated markets with respect to both the products and the marketing. The first part of the thesis contains a theoretical basis for determining the appropriate procedure for the entry of a new product on the market taking into account the specificities of the sector. The second part is an analysis of the environment in relation to the selection of an appropriate strategy. The last part describes the practical application of the process and an evaluation of proposals.
|
|
|
Strategy for Launching Product "A" in the Czech and Slovak Marketplaces
Kolek, Martin ; Kryglová, Ivana (referee) ; Chlebovský, Vít (advisor)
Cílem této práce je vypracovat strategii vstupu produktu "A" farmaceutické společnosti "F" na český a slovenský trh. V této práci je tato strategie analyzována a hodnocena pomocí metody NPV (Net Present Value) a dalších metod. Na základě tohoto hodnocení je strategie vybrána. První kapitola zahrnuje teoretická východiska jednotlivých metod použitých pro účely této práce. Je zde zejména osvětlena metoda NPV a metody vhodné pro analýzu relevantních trhů, společnosti "F" produktu "A". Ve druhé kapitole je provedena analýza trhu České a Slovenské republiky a také analýza společnosti "F" a produktu "A". Tyto analýzy zahrnují jak vnitřní tak vnější potenciál společnosti i produktu. V závěrečné kapitole je vypracována navrhovaná strategie vstupu pro produkt 'A', jež je poté ekonomicky hodnoceny pomocí modelu NPV a dalších modelů.
|
|
|
Vykázání neuznaných nehmotných aktiv v rozvaze: rizika a přínos
Dobrotková, Kamila ; Zelenka, Vladimír (advisor) ; Svačina, Pavel (referee)
The aim of this thesis is to analyse the research area of omitted intangible assets from the balance sheet and consider rewards of their potential recognition in the statement of financial position. The theoretical part provides the reader with the current regulation in force and compares it to the regulation prior the standardization and convergence process. The empirical part focuses on valuation of equity of three companies from the pharmaceutical industry based on the model pursued by American professor Stephen Penman. The values obtained are subsequently compared to market prices which are believed to reflect also the possession of omitted intangible assets. Differences identified speak in favour of potential recognition, however these are believed to be marginal comparing to probable inherent risks, which include, inter alia, stock market run-ups and earnings management.
|
|
|
Pharmaceutical Market in the Russian Federation and Investment Possibilities of Block, Inc.
Navrátil, Vojtěch ; Čajka, Radek (advisor) ; Bolotov, Ilya (referee)
The aim of this thesis is to describe the present situation on the Russian pharmaceutical market under the influence of the sanctions. The bachelor thesis is divided into three main chapters. The first chapter is dedicated to distribution of drugs according to the international health standards. Furthermore, there is comparison between the Russian pharmaceutical market and other markets and at the end of the chapter the structure of the market is analysed. The second chapter compares global and Russian producers, analysing five key manufacturers acting on the Russian market. State regulation is an integral part of the pharmaceutical market of every country, which is the last subchapter of this thesis. In the final chapter company Block, Inc., which produces clean rooms, especially for the pharmaceutical industry and the health sector, is introduced. At the end Block competitors are unveiled and opportunities and threats on the Russian pharmaceutical market and influence of the sanctions to the all industry are described.
|
|
|
Specifications of Enterpreneurship in a Pharmaceutical Industry
Litva, Dušan ; Hartman, Ladislav (advisor) ; Paterová, Iva (referee)
Diploma thesis is focused on specifications in pharmaceutical business. It is based on knowledge of pharmacy and economy and their synthesis is describing the most significant differences in pharmacy business and other markets. Overall goal of diploma thesis was to create overview about pharmaceutical industry, its progress, trends and behavior of companies to this high risk and volatile market with keeping the rules and norms of Czech and European authorities. Target was also to form group of recommendations for companies participated in this market. To keep this target I described in the first part of diploma thesis basic terminology and theoretical knowledge about pharmaceutical market including research and development, marketing and sales and pharmakovigilance. Practical part was based on case studies specifying the most common and difficult problems and steps leading to their solutions. My personal contribution in diploma thesis is based on detailed and professional handling of the topic and in the choice of parametres which influence the most timing and capital demands of R&D projects in pharmacy and mitigation of their negative aspects.
|
|
|
Effect of foreign investor entry on company's behavior
Marek, Jakub ; Klosová, Anna (advisor) ; Gullová, Soňa (referee)
This thesis focuses on the comparison and evaluation of two entry strategies of international pharmaceutical company Fagron on the Czech and Brazilian market. In the theoretical part the internationalization of companies and possible approaches to international business is summarized. I closely describe the most significant forms of entering foreing markets with emphasis on selected impacts of FDI to the receiving economy. Then I describe the basic analyses required to enter foreing market together with specifics of B2B markets and the specific scope of business of the company -- pharmaceutical compounding. After the introduction of company Fagron and its expansion strategy Buy-and-Build I proceed with the analyses of particular entry strategies on the selected markets with the emphasis on their strategic goals, specific impacts and meeting the goals. This part draws from carried out in-depth analyses of the selected markets, which were moved to the appendices due to the limited scope of work. In the last chapter the above-mentioned market entries are compared, with the focus on the most important similarities and differences, and subsequently evaluated.
|
|
|
Distribution network of the pharmaceutical industry
Novotná, Ivana ; Drozen, František (advisor) ; Šípek, Ladislav (referee)
This thesis deals with the descriptive analysis of entire process of the pharmaceutical industry's distribution and the verification of its effective functioning in the Czech Republic. The first part is focused on the definition of key terms and presents the theoretical basis for this thesis (specifics of pharma industry, history of pharmaceutics and pharma industry, actual situation and predictions of pharma industry). The second part is concerned the individual subjects of the distribution - pharmaceutical company, wholesaler and pharmacy.
|
|
|
Duševní vlastnictví a dostupnost léčiv: patentové pooly jako nástroje pro zvýšení dostupnosti ve farmaceutickém průmyslu
Nemkyová, Renata ; Štěrbová, Ludmila (advisor) ; Müller, David (referee)
The doctrine of intellectual property is based on the assumption that the exclusivity to commercialize a novel product granted to an inventor creates incentives to conduct research. In some areas, however, intellectual property can constitute a barrier to development of social welfare. In the area of access to medicines in developing countries, the intellectual property-related problem can take two forms. When needed products are not being developed and thus do not exist, lack of availability occurs. Lack of accessibility, on the other hand, arises when necessary medicines do exist, but their prices are prohibitive for people from resource-poor countries. Based on a detailed analysis of the patent and trade environment in the pharmaceutical sector, the thesis examines the potential of patent pooling as a joint intellectual property management strategy to increase access to medicines within the existing international intellectual property system. Particularly, it analyzes the effects of an existing pharmaceutical pool, the Medicines Patent Pool, on accessibility of antiretroviral medicines in low and middle income countries.
|
|
|
The valuation of PHOENIX lékárenský velkoobchod a.s. company
Křížek, Martin ; Kislingerová, Eva (advisor) ; Scholleová, Hana (referee)
The main goal of this master's thesis is to estimate a value of company PHOENIX lékárenský velkoobchod a.s. the largest pharmaceutical distributor in the Czech Republic as of 31st January of 2014. Information regarding the value of the company is utilized by the management of the company. First part of this thesis serves as theoretical summary of used analytical technics. The second and the most important part of this thesis focuses on estimation of the value of the company, to analyse its position on the czech market, to analyze its financial health and to prepare actual financial plan. The primary method used for evaluation of the company is free cash flow to the firm. In order to present suitable comparison, Economic Value Added method is used as well.
|
guest ::
